Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castration-resistant, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03999515
What this trial is testing

Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaDouble-Negative Prostate CarcinomaMetastatic Prostate Carcinoma+4 more
University of Washington 3
Testing effectiveness (Phase 2)Looking for participantsNCT07142551
What this trial is testing

Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Not applicableActive Not RecruitingNCT04024475
What this trial is testing

Prostate Cancer Biobank

Who this might be right for
Prostatic Neoplasms
Swiss Cancer Institute 1,323
Early research (Phase 1)Looking for participantsNCT07540572
What this trial is testing

Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

Who this might be right for
ER+, HER 2- Breast CancerNon-small Cell Lung Cancer (NSCLC)Castration-resistant Prostate Cancer (CRPC)+1 more
IDEAYA Biosciences 160
Not applicableStudy completedNCT02380274
What this trial is testing

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate CancerCastration-resistant Prostate CancerMetastatic Prostate Cancer
Astellas Pharma Global Development, Inc. 1,030
Not applicableStudy completedNCT06461689
What this trial is testing

Comparison of Changes in Tumor Burden in 68Ga-PSMA-11 PET/CT and 177Lu-PSMA SPECT/CT in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Central Hospital, Nancy, France 80
Testing effectiveness (Phase 2)Ended earlyNCT04716725
What this trial is testing

68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v8+2 more
Thomas Hope 15
Early research (Phase 1)Active Not RecruitingNCT03170960
What this trial is testing

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more
Exelixis 914
Post-approval studies (Phase 4)Study completedNCT02485691
What this trial is testing

Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent

Who this might be right for
Prostate Cancer Metastatic
Sanofi 255
Testing effectiveness (Phase 2)UnknownNCT06221774
What this trial is testing

Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors

Who this might be right for
Clear Cell Renal CarcinomaUrothelial CarcinomaMetastatic Castration-resistant Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 42
Testing effectiveness (Phase 2)Study completedNCT02903160
What this trial is testing

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer
Icahn School of Medicine at Mount Sinai 40
Testing effectiveness (Phase 2)Study completedNCT04564027
What this trial is testing

A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

Who this might be right for
Advanced Solid Tumours
AstraZeneca 54
Not applicableStudy completedNCT02424448
What this trial is testing

Study to Determine the Feasibility, Evaluability and Variability in Markers of Drug Action in Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
The Christie NHS Foundation Trust 6
Large-scale testing (Phase 3)Study completedNCT01695135
What this trial is testing

Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy

Who this might be right for
Prostate Neoplasms
Janssen Research & Development, LLC 214
Testing effectiveness (Phase 2)Ended earlyNCT00887640
What this trial is testing

Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 11
Testing effectiveness (Phase 2)UnknownNCT05156450
What this trial is testing

TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-ResistantDrug Therapy, Combination
West China Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06267729
What this trial is testing

Study of AZD0754 in Participants With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
AstraZeneca 60
Early research (Phase 1)Not Yet RecruitingNCT06866795
What this trial is testing

Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Geode Therapeutics Inc. 42
Testing effectiveness (Phase 2)Looking for participantsNCT06236139
What this trial is testing

Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Fred Hutchinson Cancer Center 48
Not applicableActive Not RecruitingNCT03611686
What this trial is testing

Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies

Who this might be right for
Metastatic Prostate Adenocarcinoma
University Hospital, Rouen 219
Next Page